Infanrix™ penta

BIOLOGICAL3 trials

Sponsors

GlaxoSmithKline

Conditions

Acellular PertussisDiphtheriaHaemophilus Influenzae Type bHepatitis BNeisseria MeningitidisPoliomyelitisTetanus

Phase 3

Long-term Persistence Study to Assess a Booster Dose of GSK Biologicals' Hib-MenC

CompletedNCT00322335

GlaxoSmithKlineHaemophilus Influenzae Type b, Neisseria Meningitidis

Start: 2006-05-31End: 2010-09-30Updated: 2016-10-20

Primary & Booster Study to Evaluate the Immunogenicity and Safety of Menitorix Vaccine in Preterm Infants

CompletedNCT00586612

GlaxoSmithKlineHaemophilus Influenzae Type b, Neisseria Meningitidis

Start: 2007-12-01End: 2008-12-30Updated: 2018-08-27

Phase 4

Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children

CompletedNCT00611559

GlaxoSmithKlineAcellular Pertussis, Diphtheria, Hepatitis B +2

Start: 2008-02-14End: 2008-06-25Updated: 2018-06-06